drugset / Trial / NCT00405535

Adjunctive Glycine for Obsessive Compulsive Disorder

NCT00405535

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine whether individuals with obsessive compulsive disorder who will take a preparation of the amino acid glycine in addition to their current treatment, may experience improvement in their symptoms.

Timeline

Start
2004-06
Primary completion
Completion
2006-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Glycine Other / unclassified 60 g Oral